RAPT Therapeutics's total assets for Q3 2025 were $165.74M, a decrease of -7.10% from the previous quarter. RAPT total liabilities were $13.76M for the fiscal quarter, a -1.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.